Patents by Inventor Urao Nonaka

Urao Nonaka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10883988
    Abstract: Definitive diagnosis and early start of treatment cannot be made for tuberculosis since conventional methods for detecting a Mycobacterium tuberculosis complex require a long time plus enormous labor and expense. Because detection is difficult to perform directly from a biological sample, if the biological sample contains no or a very small amount of the Mycobacterium tuberculosis complex-specific secretory protein, there is a risk infection with the Mycobacterium tuberculosis complex will be missed.
    Type: Grant
    Filed: April 28, 2016
    Date of Patent: January 5, 2021
    Assignee: TAUNS CO., LTD.
    Inventors: Urao Nonaka, Toshiyuki Kitagawa
  • Patent number: 10830769
    Abstract: Definitive diagnosis and early start of treatment cannot be made for tuberculosis since conventional methods for detecting a Mycobacterium tuberculosis complex require a long time plus enormous labor and expense. Because detection is difficult to perform directly from a biological sample, if the biological sample contains no or a very small amount of the Mycobacterium tuberculosis complex-specific secretory protein, there is a risk infection with the Mycobacterium tuberculosis complex will be missed.
    Type: Grant
    Filed: May 16, 2018
    Date of Patent: November 10, 2020
    Assignee: TAUNS CO., LTD
    Inventors: Urao Nonaka, Toshiyuki Kitagawa
  • Patent number: 10823730
    Abstract: Definitive diagnosis and early start of treatment cannot be made for tuberculosis since conventional methods for detecting a Mycobacterium tuberculosis complex require a long time plus enormous labor and expense. Because detection is difficult to perform directly from a biological sample, if the biological sample contains no or a very small amount of MPT64, there is a risk infection with the Mycobacterium tuberculosis complex will be missed. The present method and a kit address these long-standing needs by more rapidly and conveniently detecting a Mycobacterium tuberculosis complex, without culturing a biological sample containing the Mycobacterium tuberculosis complex, in which a biological sample is subjected to a heat-treatment so as to extracellularly secrete a Mycobacterium tuberculosis complex-specific secretory protein, particularly, MPB64, and subjecting the resulting treated sample to an immunological measurement/assay.
    Type: Grant
    Filed: April 4, 2013
    Date of Patent: November 3, 2020
    Assignee: TAUNS CO., LTD.
    Inventors: Urao Nonaka, Toshiyuki Kitagawa
  • Publication number: 20180259519
    Abstract: Definitive diagnosis and early start of treatment cannot be made for tuberculosis since conventional methods for detecting a Mycobacterium tuberculosis complex require a long time plus enormous labor and expense. Because detection is difficult to perform directly from a biological sample, if the biological sample contains no or a very small amount of the Mycobacterium tuberculosis complex-specific secretory protein, there is a risk infection with the Mycobacterium tuberculosis complex will be missed.
    Type: Application
    Filed: May 16, 2018
    Publication date: September 13, 2018
    Inventors: Urao NONAKA, Toshiyuki KITAGAWA
  • Publication number: 20160238599
    Abstract: Definitive diagnosis and early start of treatment cannot be made for tuberculosis since conventional methods for detecting a Mycobacterium tuberculosis complex require a long time plus enormous labor and expense. Because detection is difficult to perform directly from a biological sample, if the biological sample contains no or a very small amount of the Mycobacterium tuberculosis complex-specific secretory protein, there is a risk infection with the Mycobacterium tuberculosis complex will be missed.
    Type: Application
    Filed: April 28, 2016
    Publication date: August 18, 2016
    Inventors: Urao NONAKA, Toshiyuki KITAGAWA
  • Publication number: 20150064729
    Abstract: Definitive diagnosis and early start of treatment cannot be made for tuberculosis since conventional methods for detecting a Mycobacterium tuberculosis complex require a long time plus enormous labor and expense. Because detection is difficult to perform directly from a biological sample, if the biological sample contains no or a very small amount of MPT64, there is a risk infection with the Mycobacterium tuberculosis complex will be missed. The present method and a kit address these long-standing needs by more rapidly and conveniently detecting a Mycobacterium tuberculosis complex, without culturing a biological sample containing the Mycobacterium tuberculosis complex, in which a biological sample is subjected to a heat-treatment so as to extracellularly secrete a Mycobacterium tuberculosis complex-specific secretory protein, particularly, MPB64, and subjecting the resulting treated sample to an immunological measurement/assay.
    Type: Application
    Filed: April 4, 2013
    Publication date: March 5, 2015
    Inventors: Urao Nonaka, Toshiyuki Kitagawa
  • Patent number: 4038146
    Abstract: A serum sample is added to a reaction liquid obtained by adding an aqueous solution of a mixture of a tetrazolium compound and phenazine methosulfate to an enzyme-coenzyme reagent comprising LPL, GDH and NAD thereby effecting hydrolysis reaction of serum triglycerides and subsequent dehydrogenation reaction of resulting glycerol and the liquid after the reaction is subjected to colorimetry in a visible ray region to determine the triglyceride content of the serum.
    Type: Grant
    Filed: December 9, 1974
    Date of Patent: July 26, 1977
    Assignee: Latron Laboratories, Inc.
    Inventors: Urao Nonaka, Hideto Shibata, Nobuyuki Nakajima